Does gabexate mesilate affect serum concentrations of acute phase proteins after endoscopic retrograde cholangiopancreatography examination?

Hepato-Gastroenterology

Volumn 50, Issue 51, 2003, Pages 851-855

  Pezzilli, Raffaele ^a,f   Gabbrielli, Armando ^b   Morselli Labate, Antonio Maria ^a   D'Alessio, Pasquale ^b   Barakat, Bahjat ^a   Costamagna, Guido ^c   Dibenedetti, Francesco ^d   Massa, Margherita ^d   Merlini, Giovanni ^d   Melzi D'Eril, Gianvico ^e  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b UNIVERSITY CAMPUS BIO MEDICO   (Italy)

^c FONDAZIONE POLICLINICO UNIVERSITARIO A GEMELLI IRCCS   (Italy)

^d UNIVERSITY OF PAVIA   (Italy)

^e UNIVERSITY OF INSUBRIA   (Italy)

^f UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Acute Phase Proteins; Clinical Study; ERCP; Gabexate; Pancreatitis

Indexed keywords

ACUTE PHASE PROTEIN; AMYLASE; C REACTIVE PROTEIN; GABEXATE MESILATE; INTERLEUKIN 6; IOPAMIDOL; PLACEBO; SERUM AMYLOID A; TRIACYLGLYCEROL LIPASE;

ACUTE PANCREATITIS; ADULT; AGED; ARTICLE; CHRONIC PANCREATITIS; CLINICAL ARTICLE; CLINICAL TRIAL; COMMON BILE DUCT STONE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG MECHANISM; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; FEMALE; HUMAN; MALE; ODDI SPHINCTER; PANCREAS CANCER; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; VATER PAPILLA TUMOR;

ACUTE DISEASE; ACUTE-PHASE PROTEINS; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; C-REACTIVE PROTEIN; CHOLANGIOPANCREATOGRAPHY, ENDOSCOPIC RETROGRADE; FEMALE; GABEXATE; HUMANS; INFUSIONS, INTRAVENOUS; INTERLEUKIN-6; MALE; MIDDLE AGED; PANCREATITIS; PREMEDICATION; SERINE PROTEINASE INHIBITORS; SERUM AMYLOID A PROTEIN;

EID: 0038238640     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Tamura Y, Hirado M, Okamura K, Minamoto Y, Fujii S: Synthetic inhibitors of trypsin, plasmin, kallikrein, thrombin, C1r, and C1 esterase. Biochim Biophys Acta 1978; 484:417-422.
2. Freise J, Schmidt FW, Magerstedt P, Schmid K: Gabexate mesilate and camostate: New inhibitors of phospholipase A2 and their influence on the alpha-amylase activity in serum of patients with acute pancreatitis. Clin Biochem 1985; 18:224-229.
3. Kosaki G, Nomura T, Kambayashi J: The mechanism of the inhibitory effect of proteinase inhibitors on platelet aggregation and cellular synthesis of prostaglandins. I. The effect on the release of arachidonic acid from phospholipids. Thromb Res 1980; 20:587-598.
4. Cavallini G, Tittobello A, Frulloni L, Masci E, Mariani A, Di Francesco V, and the Gabexate in Digestive Endoscopy-Italian Group: Gabexate for the prevention of pancreatic damage related to endoscopic retrograde cholangiopancreatography. N Engl J Med 1996; 335:919-923.
5. Scuderi P: Suppression of human leukocyte tumor necrosis factor secretion by the serine proteinase inhibitor p-toluenesulphonyl-L-arginine methyl ester (TAME). J Immunol 1989; 143:168-173.
6. Gearing AJ, Beckett P, Christodoulou M, Churchill M, Clements J, Davidson AH, Drummond AH, Galloway WA, Gilbert R, Gordon JL: Processing of tumor necrosis factor-a precursor by metalloproteinases. Nature 1994; 370:555-557.
7. Kostura MJ, Tocci MJ, Limjuco G, Chin J, Cameron P, Hillman AG, Chartrain NA, Schmidt JA: Identification of a monocyte specific pre-interleukin 1 beta convertase activity. Proc Natl Acad Sci USA 1989; 86:5227-5231.
8. Wilson KP, Black JA, Thomson JA, Kim EE, Griffith JP, Navia MA, Murcko MA, Chambers SP, Aldape RA, Raybuck SA: Structure and mechanism of interleukin 1β converting enzyme. Nature 1994; 370:270-274.
9. Matsuda Y, Kawata S, Nagase T, Maeda Y, Yamasaki E, Kiso S, Ishiguro H, Matsuzawa Y: Interleukin-6 in transcatheter arterial embolization for patients with hepatocellular carcinoma. Effects of serine proteinase inhibitor. Cancer 1994; 73:53-57.
10. Okumura Y, Inoue H, Fujiyama Y, Bamba T: Effects of serine protease inhibitors on accumulation of polymorphonuclear leukocytes in the lung induced by acute pancreatitis in rats. J Gastroenterol 1995; 30:379-386.
11. Ito N, Kawata S, Tamura S, Kiso S, Tsushima H, Maeda Y, Yamasaki E, Igura T, Matsuzawa Y: Induction of interleukin-6 by interferon alpha and its abrogation by a serine protease inhibitor in patients with chronic hepatitis C. Hepatology 1996; 23:669-675.
12. Pezzilli R, Barakat B, Morselli-Labate AM: Evaluation of the immunomodulatory effect of gabexate mesilate in patients with severe acute pancreatitis. Curr Ther Res 1998; 59:710-716.
13. Pezzilli R, Morselli Labate AM, Miniero R, Barakat B, Fiocchi M, Cappelletti O: Simultaneous serum assays of lipase and interleukin-6 for early diagnosis and prognosis of acute pancreatitis. Clin Chem 1999; 45:1762-1767.
14. Pezzilli R, Billi P, Cappelletti O, Barakat B: Serum C-reactive protein in the acute biliary pancreatitis. Is it a reliable marker for the early assessment of severity of the disease? Ital J Gastroenterol Hepatol 1997; 29:554-557.
15. Pezzilli R, Melzi D'Eril GV, Morselli Labate AM, Merlini G, Barakat B, Bosoni T: Serum amyloid A, procalcitonin and C-reactive protein in the early assessment of the severity of acute pancreatitis. Dig Dis Sci 2000; 45:1072-1078.
16. Human IL-6 Quantikine ELISA Kit. Catalog Number D6050. R&D Systems, Inc, Minneapolis, MN, USA, Release 2000. (URL: http://www.rndsystems.com)
17. Dati F, Lammers M, Adam A, Sondag D, Stienen L: Referenzwartz fur 18 plasmaproteine am Behring-Nephelometer-System. Lab Med 1989; 13:87-90.
18. N Latex SAA. Package Insert. Dade Behring, Marburg, Germany. Release 1999.
19. Siegel S: Non-parametric statistics for the behavioral sciences. New York (NY): McGraw-Hill, 1956.
20. Snedecor GW, Cochran WG: Statistical Methods. 8th Edition. Iowa State University Press; Ames, Iowa: 1989.
21. SPSS/PC+. Base System User's Guide; Advanced Statistics. Version 5.0. SPSS Inc.; Chicago, Illinois: 1992.
22. Bradley EL: A clinically based classification system for acute pancreatitis. Summary of the International Symposium on Acute Pancreatitis, Atlanta, GA, September 11 trough 13, 1992. Arch Surg 1993; 128:586-590.
23. Kunz D, Bank U, Ittenson A, Schulz HU, Sokolowski A: Alteration of immunological functions in acute pancreatitis. Eur J Clin Chem Clin Biochem 1993; 31:A35-36.
24. Kiviniemi H, Juvonen T, Makela J: Acute phase response in patients with uncomplicated endoscopic retrograde cholangiopancreatography. HPB Surg 1994; 8:129-131.
25. Oezcueruemez-Porsch M, Kunz D, Hardt PD, Fadgyas T, Kress O, Schulz HU, Schnell-Kretschmer H, Temme H, Westphal S, Luley C, Kloer HU: Diagnostic relevance of interleukin pattern, acute phase proteins, and procalcitoninin early phase of post-ERCP pancreatitis. Dig Dis Sci 1998; 43:1763-1769.
26. Blanchard JA, Barve S, Joshi-Barve S, Talwalker R, Gates LK: Cytokine production by CAPAN-1 and CAPAN-2 cell lines. Dig Dis Sci 2000; 45:927-932.
27. Mahida YR, Kurlac L, Gallagher A, Hawkey CJ: High circulating concentrations of interleukin-6 in active Crohn's disease but not ulcerative colitis. Gut 1991; 32:1531-1534.
28. Pezzilli R, Billi P, Fiocchi M, Beltrandi E, Cappelletti O, Sprovieri G, Miglioli M: Serum beta 2-microglobulin in chronic diseases of the pancreas. Int J Pancreatol 1995; 17:161-166.
29. Sipe D: Amyloidosis and the acute phase response. Folia Histochem Cytobiol 1992; 30:171-173.
30. Pezzilli R, Billi P, Miniero R, Fiocchi M, Cappelletti O, Morselli-Labate AM, Barakat B, Sprovieri G, Miglioli M: Serum interleukin 6, interleukin 8 and β2 microglobulin in the early assessment of the severity of acute pancreatitis. A comparison with serum C-reactive protein. Dig Dis Sci 1995; 40:2341-2348.
31. Messman H, Vogt W, Holstege A, Lock G, Heinish A, von Furstenberg A, Leser HG, Zirngibl H, Scholmerich J: Post-ERCP pancreatitis as a model for cytokine induced response in acute pancreatitis. Gut 1997; 40:80-85.
32. Leser HG, Gross V, Scheibenbogen C, Heinisch A, Salm R, Lausen M, Rukauer K, Andreesen R, Farthmann EH, Scholmerich J: Elevation of serum interleukin-6 concentrations precedes acute-phase response and reflects severity in acute pancreatitis. Gastroenterology 1991; 101:782-785.